Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Correlation of netilmicin agar dilution and disk diffusion susceptibilities.

Literature DB >> 900923

Correlation of netilmicin agar dilution and disk diffusion susceptibilities.

D A Goldmann, G P Syriopoulou, A M Semple.

Abstract

A study of 283 isolates of gram-negative bacilli revealed a good correlation (r = -0.74) between disk diffusion zones of inhibition and agar dilution minimal inhibitory concentrations. Regression analysis suggested that strains with zone sizes =/<11 mm should be considered resistant, but 34 of 45 strains resistant by minimal inhibitory concentration (including 27 strains of Pseudomonas aeruginosa) would have been called susceptible using this break point.

Entities: Species

Mesh：

Substances：

Year: 1977 PMID： 900923 PMCID： PMC429900 DOI： 10.1128/AAC.12.2.288

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

9 in total

1. Antibiotic susceptibility testing by a standardized single disk method.

Authors: A W Bauer; W M Kirby; J C Sherris; M Turck
Journal: Am J Clin Pathol Date: 1966-04 Impact factor: 2.493

2. Comparative in vitro activity of Sch 20656, netilmicin, gentamicin, and tobramycin.

Authors: C Watanakunakorn
Journal: Antimicrob Agents Chemother Date: 1976-08 Impact factor: 5.191

3. In vitro study of netilmicin compared with other aminoglycosides.

Authors: K P Fu; H C Neu
Journal: Antimicrob Agents Chemother Date: 1976-09 Impact factor: 5.191

4. Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic.

Authors: G H Miller; G Arcieri; M J Weinstein; J A Waitz
Journal: Antimicrob Agents Chemother Date: 1976-11 Impact factor: 5.191

5. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.

Authors: R D Meyer; L L Draus; K A Pasieczinik
Journal: Antimicrob Agents Chemother Date: 1976-10 Impact factor: 5.191

6. Sisomicin versus netilmicin: in vitro susceptibility testing.

Authors: D J Flournoy
Journal: Antimicrob Agents Chemother Date: 1976-11 Impact factor: 5.191

7. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae.

Authors: D J Briedis; H G Robson
Journal: Antimicrob Agents Chemother Date: 1976-10 Impact factor: 5.191

8. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms.

Authors: J J Rahal; M S Simberkoff; K Kagan; N H Moldover
Journal: Antimicrob Agents Chemother Date: 1976-04 Impact factor: 5.191

9. In vitro comparison of gentamicin, tobramycin, sisomicin, and netilmicin.

Authors: K N Brown; J Benedictson; S Swanby
Journal: Antimicrob Agents Chemother Date: 1976-10 Impact factor: 5.191

9 in total

5 in total

Correlation of netilmicin agar dilution and disk diffusion susceptibilities.

1. Antibiotic susceptibility testing by a standardized single disk method.

2. Comparative in vitro activity of Sch 20656, netilmicin, gentamicin, and tobramycin.

3. In vitro study of netilmicin compared with other aminoglycosides.

4. Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic.

5. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.

6. Sisomicin versus netilmicin: in vitro susceptibility testing.

7. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae.

8. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms.

9. In vitro comparison of gentamicin, tobramycin, sisomicin, and netilmicin.

1. Quality control parameters for susceptibility tests with 30-micrograms netilmicin disks.

2. Tentative interpretive criteria for the diffusion susceptibility test using 30-microgram netilmicin disks.

3. Correlation of netilmicin disk diffusion susceptibility and agar dilution susceptibility.

Review 4. Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.

Review 5. Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.